These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29775303)

  • 21. Functionalizing αvβ3- or α5β1-selective integrin antagonists for surface coating: a method to discriminate integrin subtypes in vitro.
    Rechenmacher F; Neubauer S; Polleux J; Mas-Moruno C; De Simone M; Cavalcanti-Adam EA; Spatz JP; Fässler R; Kessler H
    Angew Chem Int Ed Engl; 2013 Jan; 52(5):1572-5. PubMed ID: 23345131
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
    Conradi J; Huber S; Gaus K; Mertink F; Royo Gracia S; Strijowski U; Backert S; Sewald N
    Amino Acids; 2012 Jul; 43(1):219-32. PubMed ID: 21915696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apoptosis therapy in cancer: the first single-molecule co-activating p53 and the translocator protein in glioblastoma.
    Daniele S; Taliani S; Da Pozzo E; Giacomelli C; Costa B; Trincavelli ML; Rossi L; La Pietra V; Barresi E; Carotenuto A; Limatola A; Lamberti A; Marinelli L; Novellino E; Da Settimo F; Martini C
    Sci Rep; 2014 Apr; 4():4749. PubMed ID: 24756113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.
    Daniele S; Barresi E; Zappelli E; Marinelli L; Novellino E; Da Settimo F; Taliani S; Trincavelli ML; Martini C
    Oncotarget; 2016 Feb; 7(7):7866-84. PubMed ID: 26761214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A stapled peptide antagonist of MDM2 carried by polymeric micelles sensitizes glioblastoma to temozolomide treatment through p53 activation.
    Chen X; Tai L; Gao J; Qian J; Zhang M; Li B; Xie C; Lu L; Lu W; Lu W
    J Control Release; 2015 Nov; 218():29-35. PubMed ID: 26428461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of αvβ₃- and α₅β₁-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics.
    Tolomelli A; Baiula M; Belvisi L; Viola A; Gentilucci L; Troisi S; Dattoli SD; Spampinato S; Civera M; Juaristi E; Escudero M
    Eur J Med Chem; 2013 Aug; 66():258-68. PubMed ID: 23811088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin α5β1 plays a critical role in resistance to temozolomide by interfering with the p53 pathway in high-grade glioma.
    Janouskova H; Maglott A; Leger DY; Bossert C; Noulet F; Guerin E; Guenot D; Pinel S; Chastagner P; Plenat F; Entz-Werle N; Lehmann-Che J; Godet J; Martin S; Teisinger J; Dontenwill M
    Cancer Res; 2012 Jul; 72(14):3463-70. PubMed ID: 22593187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single and combined effects of alphavbeta3- and alpha5beta1-integrins on capillary tube formation in a human fibrinous matrix.
    Laurens N; Engelse MA; Jungerius C; Löwik CW; van Hinsbergh VW; Koolwijk P
    Angiogenesis; 2009; 12(3):275-85. PubMed ID: 19449108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclic RGD peptidomimetics containing 4- and 5-amino-cyclopropane pipecolic acid (CPA) templates as dual αVβ3 and α5β1 integrin ligands.
    Sernissi L; Trabocchi A; Scarpi D; Bianchini F; Occhiato EG
    Bioorg Med Chem; 2016 Feb; 24(4):703-11. PubMed ID: 26753814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
    Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
    J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. αvβ3 and α5β1 integrin-specific ligands: From tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine?
    Rocha LA; Learmonth DA; Sousa RA; Salgado AJ
    Biotechnol Adv; 2018; 36(1):208-227. PubMed ID: 29155160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair.
    Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT
    Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells.
    Renner G; Noulet F; Mercier MC; Choulier L; Etienne-Selloum N; Gies JP; Lehmann M; Lelong-Rebel I; Martin S; Dontenwill M
    Oncotarget; 2016 Sep; 7(38):62194-62207. PubMed ID: 27613837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lead Optimization of 2-Phenylindolylglyoxylyldipeptide Murine Double Minute (MDM)2/Translocator Protein (TSPO) Dual Inhibitors for the Treatment of Gliomas.
    Daniele S; La Pietra V; Barresi E; Di Maro S; Da Pozzo E; Robello M; La Motta C; Cosconati S; Taliani S; Marinelli L; Novellino E; Martini C; Da Settimo F
    J Med Chem; 2016 May; 59(10):4526-38. PubMed ID: 27050782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
    Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
    Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation.
    Wu H; Jiang J; Xu H; Li Q; Cai J
    Expert Opin Ther Pat; 2016; 26(1):131-7. PubMed ID: 26560186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral ischemia-induced angiogenesis is dependent on tumor necrosis factor receptor 1-mediated upregulation of α5β1 and αVβ3 integrins.
    Huang H; Huang Q; Wang F; Milner R; Li L
    J Neuroinflammation; 2016 Sep; 13(1):227. PubMed ID: 27586239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin.
    Yokosaki Y; Tanaka K; Higashikawa F; Yamashita K; Eboshida A
    Matrix Biol; 2005 Sep; 24(6):418-27. PubMed ID: 16005200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding.
    Wei Y; Czekay RP; Robillard L; Kugler MC; Zhang F; Kim KK; Xiong JP; Humphries MJ; Chapman HA
    J Cell Biol; 2005 Jan; 168(3):501-11. PubMed ID: 15684035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Side chain effect in the modulation of α
    Ferrazzano L; Corbisiero D; Potenza E; Baiula M; Dattoli SD; Spampinato S; Belvisi L; Civera M; Tolomelli A
    Sci Rep; 2020 May; 10(1):7410. PubMed ID: 32366988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.